ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

VERU Veru Inc

0.85
-0.0388 (-4.37%)
13 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Veru Inc VERU NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0388 -4.37% 0.85 18:50:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.90 0.8311 0.923381 0.8385 0.8888
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/6/202407:30GLOBEVeru to Present at the American Diabetes Association's 84th..
28/5/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202417:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202417:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:10EDGAR2Form 8-K - Current report
22/5/202407:30GLOBEVeru to Present at the Jefferies Global Healthcare..
17/5/202418:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202407:30GLOBEVeru Announces Steven B. Heymsfield M.D. as the Principal..
14/5/202407:30GLOBEVeru Announces Mitchell Steiner as Keynote Speaker at Biomed..
09/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202414:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202414:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202412:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202412:02EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
08/5/202412:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202406:00EDGAR2Form 8-K - Current report
08/5/202405:30GLOBEVeru Reports Fiscal 2024 Second Quarter Financial Results..
02/5/202407:30GLOBEVeru to Present at the GLP-1 Based Therapeutics Summit
01/5/202407:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
30/4/202407:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
25/4/202407:30GLOBEVeru to Present at the American Association of Clinical..
01/4/202415:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
22/3/202415:05GLOBEVeru Reschedules Annual Meeting of Shareholders
12/3/202407:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
27/2/202418:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
20/2/202407:30GLOBEVeru Announces New Scientific Advisory Board for its..
15/2/202415:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/2/202415:06EDGAR2Form 8-K - Current report
14/2/202415:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202406:00EDGAR2Form 8-K - Current report
08/2/202405:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
06/2/202415:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202407:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
31/1/202407:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
26/1/202415:06EDGAR2Form 8-K - Current report
26/1/202408:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202408:00EDGAR2Form DEF 14A - Other definitive proxy statements
25/1/202407:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
08/1/202407:30GLOBEVeru Submits IND Application to FDA for the Development of..
26/12/202315:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202307:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
18/12/202308:01EDGAR2Form 8-K - Current report
15/12/202315:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202308:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
13/12/202315:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202315:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202315:04EDGAR2Form 8-K - Current report
13/12/202315:01GLOBEVeru Announces Proposed Public Offering of Common Stock

Su Consulta Reciente

Delayed Upgrade Clock